ClearPoint Neuro, Inc. Income Taxes Disclosure
13. Income Taxes
The Company adopted ASU 2023-09 “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” on a prospective basis beginning with the year ended December 31, 2025. The following table presents required disclosures pursuant to ASU 2023-09 and reconciles the U.S. federal statutory tax amount to the actual global effective amount and rate for the year ended December 31, 2025.
|
|
Year Ended December 31, 2025 |
|
|||||
|
|
Amount (in thousands) |
|
|
Percent |
|
||
U.S. Federal Statutory Rate |
|
$ |
(5,378 |
) |
|
|
21.0 |
% |
State and local income taxes, net of federal income tax effect (a) |
|
|
22 |
|
|
|
-0.1 |
% |
Foreign tax effects |
|
|
33 |
|
|
|
-0.1 |
% |
Effects of changes in tax laws or rates enacted in the current period |
|
|
— |
|
|
|
— |
|
Effects of cross-border tax laws |
|
|
— |
|
|
|
— |
|
Tax credits |
|
|
— |
|
|
|
— |
|
Changes in valuation allowance |
|
|
5,124 |
|
|
|
20.0 |
% |
Nontaxable and nondeductible items |
|
|
|
|
|
|
||
Excess share-based compensation |
|
|
(41 |
) |
|
|
0.2 |
% |
Other |
|
|
295 |
|
|
|
-1.2 |
% |
Changes in unrecognized tax benefit |
|
|
— |
|
|
|
— |
|
Other adjustments |
|
|
— |
|
|
|
— |
|
Effective tax rate |
|
$ |
55 |
|
|
|
-0.2 |
% |
|
|
|
|
|
|
|
||
(a) State taxes in South Carolina, Massachusetts and New Jersey made up the majority (greater than 50%) of the tax effect in this category. |
|
|||||||
|
|
|
|
|
|
|
||
The following table presents the required disclosures prior to adoption of ASU 2023-09 and reconciles the U.S. federal statutory income tax rate to the actual global effective amount and rate for the year ended December 31, 2024.
|
|
Year Ended December 31, |
|
|
(in thousands) |
|
2024 |
|
|
Income tax benefit at federal statutory rate |
|
$ |
(3,992 |
) |
Adjustments for tax effects of: |
|
|
|
|
State income tax, net of federal benefit |
|
|
(650 |
) |
Permanent adjustments |
|
|
305 |
|
Benefit state rate change |
|
|
136 |
|
Other |
|
|
144 |
|
Share-based compensation |
|
|
1,336 |
|
Net operating loss write-off |
|
|
216 |
|
Change in valuation allowance |
|
|
2,517 |
|
Income tax expense |
|
$ |
12 |
|
The tax effect of temporary differences and carryforwards that give rise to significant portions of the deferred income tax assets are as follows:
|
|
Years Ended December 31, |
|
|||||
(in thousands) |
|
2025 |
|
|
2024 |
|
||
Deferred income tax assets: |
|
|
|
|
|
|
||
Net operating loss carryforwards |
|
$ |
64,837 |
|
|
$ |
31,776 |
|
Share-based compensation |
|
|
1,300 |
|
|
|
1,390 |
|
Accrued expenses |
|
|
747 |
|
|
|
295 |
|
174 Capitalization |
|
|
— |
|
|
|
4,606 |
|
Unrealized FX (gain)/loss |
|
|
5 |
|
|
|
— |
|
Other |
|
|
408 |
|
|
|
267 |
|
|
|
|
67,297 |
|
|
|
38,334 |
|
Less valuation allowance |
|
|
(64,155 |
) |
|
|
(38,333 |
) |
Total deferred income tax assets |
|
|
3,142 |
|
|
|
1 |
|
Deferred tax liability - property and equipment |
|
|
(117 |
) |
|
|
— |
|
Deferred tax liability - intangibles |
|
|
(3,379 |
) |
|
|
— |
|
Deferred tax liability - unrealized FX (gain)/loss |
|
|
— |
|
|
|
(1 |
) |
Net deferred tax assets |
|
$ |
(354 |
) |
|
$ |
— |
|
In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. Generally, the ultimate realization of deferred tax assets is dependent on the generation of future taxable income during the periods in which those temporary differences become deductible. Based on all relevant factors, a valuation allowance of $64.2 million has been established against deferred tax assets as of December 31, 2025, as management determined that it is more likely than not that sufficient taxable income will not be generated to realize those temporary differences.
The net deferred tax liability of $0.4 million as of December 31, 2025 relates to the acquisition of IRRAS, primarily related to book intangibles (with finite useful lives for book purposes and carryover tax basis) partially offset by tax net operating losses. As of December 31, 2024, the Company had no material net deferred tax liability and maintained a full valuation allowance against its net deferred income tax assets due to uncertainties surrounding their realization in future periods. Due to the timing of the acquisition late in 2025, any partial release of the valuation allowance would be reflected in the year ended December 31, 2025, and future periods as evidence of realizability evolves. The Company is subject to multiple state minimum income tax expenses for the years ended December 31, 2025 and 2024. If it is determined in the future that it is more likely than not that any deferred income tax assets are realizable, the valuation allowance will be reduced by the estimated net realizable amounts.
At December 31, 2025, the Company had net operating loss carryforwards of approximately $258.2 million and $163.1 million available to reduce future taxable income, if any, for federal and state income tax purposes, respectively. The federal net operating loss carryforwards begin expiring in 2026, and the state net operating loss carryforwards will begin expiring in 2028. It is possible that the Company will not generate taxable income in time to use these net operating loss carryforwards before their expiration. In addition, under Section 382 of the Internal Revenue Code of 1986 (the “Code”), as amended, if a corporation undergoes an “ownership change” (as defined in the Code), the corporation’s ability to use its pre-change tax attributes to offset its post-change income may be limited. In general, an “ownership change” occurs if there is a cumulative change in a “loss corporation’s” (as defined in the Code) ownership by 5% shareholders that exceeds 50 percentage points over a rolling three-year period.
Management has evaluated the effect of guidance provided by GAAP regarding accounting for uncertainty in income taxes and determined the Company has no uncertain tax positions that could have a significant impact on its consolidated financial statements. The Company’s federal income tax return for 2022 and subsequent years remain open for examination.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Mar 17, 2026 | Showing above |
| 2024 | Feb 26, 2025 | |
| 2023 | Mar 12, 2024 | |
| 2022 | Mar 1, 2023 | |
| 2021 | Mar 9, 2022 | |
| 2020 | Mar 22, 2021 | |
| 2019 | Mar 27, 2020 | |
| 2018 | Apr 1, 2019 | |
| 2017 | Mar 21, 2018 | |
| 2016 | Mar 9, 2017 | |
| 2015 | Mar 25, 2016 | |
About Income Taxes Disclosures
The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.
Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.